...
首页> 外文期刊>Protein engineering design & selection: PEDS >Efficiency of puromycin-based technologies mediated by release factors and a ribosome recycling factor
【24h】

Efficiency of puromycin-based technologies mediated by release factors and a ribosome recycling factor

机译:释放因子和核糖体循环因子介导的基于嘌呤霉素的技术的效率

获取原文
获取原文并翻译 | 示例
           

摘要

The identification of protein-protein interaction (PPI) networks is an important aspect of proteomics research. In vitro selection experiments using mRNA display methods, which were originally developed for evolutionary protein engineering, such as in vitro virus (IW) (Nemoto et al, 1997; Miyamoto-Sato et al, 2000; Miyamoto-Sato et al, 2003) or mRNA-peptide fusions (Roberts and Szostak, 1997; Hammond et al, 2001; Keefe and Szostak, 2001), are powerful tools for the analysis of protein function (Amstutz et al, 2001, Miyamoto-Sato et al, 2010). During the course of IW development (Nemoto et al, 1997), two useful puromycin-based techniques (known as 'puromycin TTnive.rsitv PrpQQ technology', Fig. 1A and B) were developed based on the observation that puromycin can bind the C-terminus of a full-length protein (Miyamoto-Sato et al, 2000). One of these puromycin-based techniques is IW formation (Nemoto et al, 1997), whereby an in v/fra-translated full-length protein (phenotype) is attached to its encoding mRNA (genotype). The second puromycin-based technique is C-terminal protein labelling {Nemoto et al, 1999; Miyamoto-Sato et al, 2000; Doi et al, 2002), in which a puromycin derivative bearing a fluorescent moiety is used to label the C-terminal end of a full-length protein. Thus, high-throughput in vitro protein selection may be achieved by combining IW and post-selection analysis (to confirm PPIs) using C-terminally labelled proteins, particularly during proteome exploration.
机译:蛋白质间相互作用(PPI)网络的识别是蛋白质组学研究的重要方面。使用mRNA展示方法的体外选择实验,最初是为进化蛋白工程开发的,例如体外病毒(IW)(Nemoto等,1997; Miyamoto-Sato等,2000; Miyamoto-Sato等,2003)或mRNA-肽融合体(Roberts和Szostak,1997; Hammond等,2001; Keefe和Szostak,2001)是分析蛋白质功能的有力工具(Amstutz等,2001; Miyamoto-Sato等,2010)。在IW开发过程中(Nemoto等,1997),基于嘌呤霉素可以结合C的观察,开发了两种有用的基于嘌呤霉素的技术(称为“ puromycin TTnive.rsitv PrpQQ技术”,图1A和B)。全长蛋白质的末端(Miyamoto-Sato等,2000)。这些基于嘌呤霉素的技术之一是IW的形成(Nemoto等,1997),其中,在v / fra内翻译的全长蛋白(表型)附着于其编码的mRNA(基因型)。第二种基于嘌呤霉素的技术是C末端蛋白标记(Nemoto等,1999; Nature,2003; 3,2,3,4,5,4,5,5,6,7,12)。 Miyamoto-Sato等人,2000; (Doi等,2002),其中带有荧光部分的嘌呤霉素衍生物用于标记全长蛋白质的C-末端。因此,通过结合使用IW和使用C末端标记的蛋白质的选择后分析(以确认PPI),可以实现高通量的体外蛋白质选择,特别是在蛋白质组探索期间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号